Muscular Diseases D009135

Diseases [C] » Musculoskeletal Diseases [C05] » Muscular Diseases

Diseases [C] » Nervous System Diseases [C10] » Neuromuscular Diseases » Muscular Diseases

Description

Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.   MeSH

Subtype Terms (27)

Arthrogryposis
3 experimental drugs

Compartment Syndromes
9 drugs (7 approved, 2 experimental)

Contracture
17 drugs (12 approved, 5 experimental)

Craniomandibular Disorders
56 drugs (35 approved, 21 experimental)

Eosinophilia-Myalgia Syndrome
 

Fatigue Syndrome, Chronic
49 drugs (31 approved, 18 experimental)

Fibromyalgia
113 drugs (73 approved, 40 experimental)

Isaacs Syndrome
 

Medial Tibial Stress Syndrome
 

Mitochondrial Myopathies
19 drugs (5 approved, 14 experimental)

Muscle Cramp
35 drugs (27 approved, 8 experimental)

Muscle Neoplasms
3 approved drugs

Muscle Rigidity
5 approved drugs

Muscle Spasticity
53 drugs (28 approved, 25 experimental)

Muscle Weakness
84 drugs (53 approved, 31 experimental)

Muscular Disorders, Atrophic
136 drugs (57 approved, 79 experimental)

Musculoskeletal Pain
113 drugs (67 approved, 46 experimental)

Myalgia
79 drugs (48 approved, 31 experimental)

Myofascial Pain Syndromes
147 drugs (89 approved, 58 experimental)

Myopathies, Structural, Congenital
3 experimental drugs

Myositis
82 drugs (52 approved, 30 experimental)

Myotonic Disorders
11 drugs (6 approved, 5 experimental)

Myotoxicity
 

Paralyses, Familial Periodic
3 approved drugs

Polymyalgia Rheumatica
34 drugs (30 approved, 4 experimental)

Rhabdomyolysis
3 approved drugs

Tendinopathy
93 drugs (51 approved, 42 experimental)


Phase 4 Indicated Drugs (104)

Key: D009135 (6) Subtype (98)

Phase 3 Indicated Drugs (138)

Key: D009135 (11) Subtype (127)

Phase 2 Indicated Drugs (201)

Key: D009135 (11) Subtype (190)

Other Experimental Indicated Drugs (88)

Key: D009135 (6) Subtype (82)


Organization Involved with Phase 4 Indications (224)

Key: D009135 (9) Subtype (215)

Organization Involved with Phase 3 Indications (286)

Key: D009135 (11) Subtype (275)

Abbott

AbbVie

ABC Foundation School of Medicine

Acorda Therapeutics

Aepodia

Aix-University of Marseille

Ajou University

Albert Einstein Israelite Hospital

Alexion

Almirall

Ambulancia Klinickej onkologie FNsP Nove Zamky

American Fibromyalgia Syndrome Association

AMO Pharma Limited

Aragon Institute of Health Sciences

arGEN-X BVBA

Asahi Kasei Pharma

Aspreva Pharmaceuticals

Assistance Publique - Hôpitaux de Paris

Astellas

Athens Orthopedic Clinic

Badalona Hospital Germans Trias i Pujol

Bajcsy-Zsilinszky Hospital

Ballarat Health Services

Basque Health Service

Bateman Horne Center

Bioblast Pharma Ltd.

BioCryst

Biolab Sanus Farmaceutica

Biomarin

Bionorica

Biospecifics Technologies Corp.

Biovirtus

Birch Point Medical

Bristol-Myers Squibb

British Columbia Cancer Agency

Brown University

Canadian Society of Plastic Surgeons

Carlo Besta Neurological Institute

Catabasis

Catalyst Pharmaceuticals, Inc.

Central Hospital Saint Quentin

Central Norway Regional Health Authority

Centre de Recherche Rhumatologique et Thermal

Centro Universitario La Salle

Cerimon Pharmaceuticals

Chang Gung University

Children's National Medical Center

China National Biotec Group Co., Ltd

Chinese Academy of Medical Sciences

Chinese University of Hong Kong

Chonbuk National University

Clementia Pharmaceuticals Inc.

Clinica Virgen Milagrosa

Complexo Hospitalario Universitario de A Coruña

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cooperative International Neuromuscular Research Group

Corbus Pharmaceuticals Inc.

Cromsource

CSL Behring

CuraVac

Delivra, Inc.

Departmental Hosptital of Vendee

Department of Defense

Department of Health and Human Services

Dojode, Chetan M., MBBS, MS

Dongguk University

Dutch Health Care Insurance Board

East Carolina University

Elan Pharmaceuticals

EMS S/A

Faculdade de Medicina do ABC

Federal University of Bahia

Federal University of Health Science of Porto Alegre

Federal University of Minas Gerais

Federal University of Rio Grande do Sul

FibroGen

Flinders University

Fondazione IRCCS Eugenio Medea

Food and Drug Administration

Fundacao Antonio Prudente

Fundacio Lluita Contra la SIDA

Fundacion Favaloro Para La Docencia e Investigacion Medica

Genzyme

GNI Group

Good Samaritan Regional Medical Center, Oregon

Government of Hong Kong

Government of Japan

Government of Spain

Green Cross Corporation

GW Research

Hallym University

Hanmi Pharmaceutical

Helse Møre og Romsdal HF

Hemispherx Biopharma

Hengrui Therapeutics, Inc.

Hetenyi G Korhaz

Hôpital Raymond Poincaré

Hospicjum im. Ks. Eugeniusza Dutkiewicza SAC w Gdansku

Hospital de Cancer de Barretos - Fundacao Pio XII

Hospital de Santa Maria, Portugal

Hospital Egas Moniz

Hospital Sanitas La Moraleja

Hospital Universitario Central de Asturias

Hospital Universitario Fundación Alcorcón

Hugel

Humboldt University

Hunter-Hopkins Center, P.A.

IDEA AG

Immunex

Impax Laboratories

INC Research

Institut fur Klinische Forschung, Germany

Institut National de la Santé Et de la Recherche Médicale, France

Instituto de Oncologia de Rosario

Instituto do Cancer do Estado de São Paulo

inVentiv

Isfahan University

Italfarmaco

Japan Blood Products Organization

Japan Medical Association

Jawaharlal Nehru Medical College

J&M Shuler

Kanazawa University

Kangbuk Samsung Hospital

Katholieke Universiteit Leuven

Keimyung University

Klinikum Klagenfurt

Kwong Wah Hospital

Laboratorio Brasileiro de Biologia

Laboratório Teuto Brasileiro S/A

Laval University

Leiden University

L'Hospitalet de Llobregat

Ludwig Maximilians University

Lupin

Mahatma Gandhi Institute of Medical Sciences

Mahidol University

Masarykuv onkologicky ustav, Klinika komplexni onkologicke pece

MEandYou Foundation

Medical University of Vienna

MEDRx Co., Ltd.

MedStar Cardiovascular Research Network

Merck KGaA

Methodist Cancer Center, Houston, Texas

MiMedx Group, Inc.

Mitsubishi Tanabe

Monash University

National Center for Research Resources (NCRR)

National Cheng Kung University

National Institute of Neurological Disorders and Stroke (NINDS)

National Natural Science Foundation of China

Nemocnice Horovice

Neurana Pharmaceuticals, Inc.

Neurology Center of New England P.C.

Newcastle University

New World Development Company Limited

New York Presbyterian Hospital

Niepliczny Zakad Opieki Zdrowotnej Zespo Medyczno-Opieku-Czy Alicja Kluczna

Nishinomiya Municipal Central Hospital

Northwell Health

Nuhr Medical Center

Octapharma

Ohio State University

Oncocenter Onclogie Clinica S.R.L

Oncolab SRL

Oncology department of Nemocnice Benesov

Orion Corporation

Orphazyme

Osmotica Pharmaceutical

Otsuka

People's Liberation Army of China

Pierre Fabre

Polyclinique de L'ormeau

Poradnia Medycyny Paliatywnej Hospicjum Palium

Powiatowy Zespo Zakadow Opieki Zdrowotnej w Bdzinie, Oddzia Opieki Paliatywnej Szpital Czelad

PPD

Premier Research Group

PTC Therapeutics

R3 Stem Cell

Ra Pharmaceuticals

Regeneron

Reneo Pharma Ltd

Reumafonds

Rouen Normandy University

Royal Berkshire and Battle Hospitals NHS Trust

Sanera, s.r.o.

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Santhera

S.C. Corinthians Paulista

Shaheed Zulfiqar Ali Bhutto Medical University

Shionogi

Silesian University of Medicine

Slovak Research Center

Sorbonne University

SPARC

Sport Science Association of Alberta

State University of New York, Buffalo

Stealth BioTherapeutics Inc.

St. Marianna University School of Medicine

Stowarzyszenie Przyjacio Chorych Hospicjum

Strategic Science & Technologies, LLC

Sue Ryder Home

Sungkyunkwan University

Sutter Health

Symyoo

Tanta University

Telemark Hospital Trust

The Charlotte-Mecklenburg Hospital Authority

The Cleveland Clinic

The Kavli Foundation

The National Cancer Center

The Norwegian ME association

Tokyo Medical and Dental University

Tonix Pharmaceuticals

Touro University

Tsinghua University

UCB

Ultragenyx Inc.

United States Air Force

United States Navy

Université catholique de Louvain

University Alicante

University Clermont Auvergne

University Hospital, Basel, Switzerland

University Hospital Plymouth NHS Trust

University of Alabama, Birmingham

University of Alberta

University of Antwerp

University of Arizona

University of Barcelona

University of Basel

University of Bern

University of Bordeaux

University of Bristol

University of Burgundy

University of Cantabria

University of Chile

University of Colorado

University of Colorado, Denver

University of East Anglia

University of Edinburgh

University of Florida

University of Franche-Comté

University of Freiburg

University of Groningen

University of Guelph

University of Illinois at Chicago

University of Indonesia

University of Kansas

University of Lille

University of Limoges

University of Lyon

University of Miami

University of Milan

University of Monastir

University of Nice Sophia Antipolis

University of Padova

University of Pavia

University of Picardie Jules Verne

University of Plymouth

University of Rennes

University of Saskatchewan

University of South Florida

University of Stavanger

University of Texas, San Antonio

University of Tokushima

University of Ulsan

University of Utah

University of Valencia

University of Versailles

University of Western Brittany

US WorldMeds

Valenciennes Hospital Centre

Velindre NHS Trust

Viela Bio

VITAE NATURAL NUTRITION, S.L.

Vita-Salute University of Milano. Italy

Vivatech

Vivex Biomedical, Inc.

Wake Forest University

Wave Life Sciences

Weleda AG

Wilhelminenspital der Stadt Wien

X-pert Med GmbH

Yangzhou No.1 People's Hospital

ZGT Almelo

Organization Involved with Phase 2 Indications (234)

Key: D009135 (13) Subtype (221)

Mansoura University

Marinus Pharmaceuticals

Mayday Fund

McGill University

MedImmune

Milo Therapeutics

Momenta Pharmaceuticals

Murdoch University

Myonexus Therapeutics

National Cancer Institute (NCI)

National Center for Advancing Translational Science (NCATS)

National Center for Complementary and Integrative Health (NCCIH)

National Center of Neurology and Psychiatry, Japan

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Nursing Research (NINR)

National Multiple Sclerosis Society

National University of Ireland

Neovacs

New York School of Regional Anesthesia

Nobel Pharmaceuticals

Northwestern University

OMNI Medical Services, LLC

Orebro University

Orphan Disease Treatment Institute Co., Ltd.

Ortopedicko-Traumatologicka Klinika, Kosice, Slovak Republic

Pacira Pharmaceuticals

Parexel

Park Nicollet

Peking University

PharmaLundensis AB

PharPoint Research, Inc.

Phrixus Pharmaceuticals, Inc.

Pomeranian Medical University

Probare i Lund AB

Quadram Institute

Queensland University of Technology

Reata Pharmaceuticals, Inc.

Region Örebro County

Region Västmanland

RemeGen

ResearchPoint Global

Revance Therapeutics, Inc.

ReveraGen BioPharma, Inc.

Rhode Island Hospital

Rho, Inc.

RiboCor, Inc.

Riphah International University

Roberson Foundation

Royal Holloway University

Royal National Orthopaedic Hospital NHS Trust

RSPR Pharma AB

Shantou University

Soleno Therapeutics, Inc.

Solid Biosciences

Sosei

Spherium Biomed

Sponsor GmbH

Stem Cells Arabia

Stroke Research Network

St Vincent's University Hospital, Ireland

Summit Therapeutics

Surya Orthopedic Clinic

SWBH NHS Trust

Syneos Health

Teva

The Heartbeat Trust

The Manitoba Spinal Cord Injury Research Fund

Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS)

Theravance

The Royal College of Physicians and Surgeons of Canada

Thomas Jefferson University

Travanti Pharma Inc.

Tulane University

Umea University

Unidade Local de Saúde do Alto Minho

Uniformed Services University of the Health Sciences

Universidad Rey Juan Carlos

Universitat Internacional de Catalunya

University of Amsterdam

University of Birmingham

University of California, San Francisco

University of Catania

University of Gothenburg

University of Kentucky

University of Kiel

University of Manchester

University of Manitoba

University of Maryland

University of Melbourne

University of North Carolina at Chapel Hill

University of Oxford

University of Poitiers

University of Southern California

University of Southern Denmark

University of Sydney

University of Tehran

University of Vermont

University of Virginia

University of Western Australia

University of Wisconsin

Virios Therapeutics

Washington University in St. Louis

Wellcome Trust

Western Michigan University

Winnipeg Regional Health Authority

Woodinville Psychiatric Associates

Workers' Compensation Board, Alberta

XenoPort, Inc.

Yale University

Zars Pharma Inc.

Zhejiang Xingyue Biotechnology Co., Ltd.

Ziekenhuis Oost-Limburg

Organization Involved with Phase 1 Indications (68)

Key: D009135 (6) Subtype (62)

Organization Involved with Other Experimental Indications (118)

Key: D009135 (5) Subtype (113)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.